Bone Biologics Corporation (BBLGW) Return on equity
Bone Biologics Corporation (BBLGW) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
No annual history for this metric yet
The company may have no SEC filings (ETF / non-US listing), or the concept is absent from its filings.
← Back to BBLGWSource: SEC XBRL filings · For reference only · Not investment advice
More BBLGW financial trends
BBLGW RevenueBBLGW Net incomeBBLGW Net marginBBLGW Gross profitBBLGW Gross marginBBLGW Operating incomeBBLGW Operating marginBBLGW Operating cash flowBBLGW Free cash flowBBLGW Capital expendituresBBLGW Stock buybacksBBLGW Dividends paidBBLGW Total assetsBBLGW Total liabilitiesBBLGW Shareholders’ equityBBLGW overview →